HIGHLIGHT
Pontevia

Pontevia

galcanezumab

Manufacturer:

Eli Lilly

Distributor:

Zuellig Pharma
Concise Prescribing Info
Contents
Galcanezumab
Indications/Uses
Preventive treatment of migraine in adults who have at least 4 migraine days mthly.
Dosage/Direction for Use
SC Initially 240 mg loading dose then 120 mg inj once mthly in abdomen, thigh, back of upper arm, or gluteal region.
Contraindications
Special Precautions
Discontinue immediately if serious hypersensitivity reaction eg, anaphylaxis, angioedema, urticaria occurs. May affect ability to drive & use machines. Avoid use during pregnancy. Lactation. Childn 6-18 yr. Elderly >65 yr.
Adverse Reactions
Inj site pain & reactions. Vertigo; constipation; pruritus.
MIMS Class
Antimigraine Preparations
ATC Classification
N02CD02 - galcanezumab ; Belongs to the class of calcitonin gene-related peptide (CGRP) antagonists preparations. Used to relieve migraine.
Presentation/Packing
Form
Pontevia soln for inj 120 mg/mL
Packing/Price
1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in